Elizabeth Dater
Senior Portfolio Manager at Forstmann Leff Assoc
Member since: Apr '04 · 14 Opinions
Rating Card
| All | 
Rating
| 
Big Win
| 
Win
| 
Neutral
| 
Loss
| 
Big Loss
|  |
|---|---|---|---|---|---|---|---|
| 0 | 0 0.00% | 0 0.00% | 0 0.00% | 0 0.00% | 0 0.00% |
Stock Opinions by Elizabeth Dater
TOP PICK
Given with what's going on with Vioxx and Cellebrex, this company is very important as the FDA will be asking for lengthier testing on these areas. Looks on this as a fabulous growth story.
biotechnology / pharmaceutical
$38.970
Owned
TOP PICK
A re-structuring story. Very successful management.
oil / gas
TOP PICK
A consolidating industry. Benefiting tremendously from technology and geographical expansion.
Unknown
TOP PICK
New entity called spoken audio content which downloads newspaper, textbooks, radio programming. A really good growth story.
Broadcasting
TOP PICK
Had a big correction so there is a buying opportunity. A story thats growing by about 20% a year. Trading at 15 X earnings.
Unknown
TOP PICK
A turn around energy story. Great, new, very proven management. Expects them to really increase their pace of exploration.
oil / gas
TOP PICK
oil / gas field services
TOP PICK
oil / gas
TOP PICK
biotechnology / pharmaceutical
TOP PICK
Has a technology that will stimulate oil production.
oil / gas
TOP PICK
biotechnology / pharmaceutical
TOP PICK
An interesting play on discretionary consumer discretionary income.
entertainment services
TOP PICK
Uses Restolane in place of Botox. Demographically very attractive.
biotechnology / pharmaceutical
TOP PICK
They have pending contracts that they have to begin to sell for Wal-Mart. Great supply chain.
electrical / electronic
Showing 1 to 14
of 14 entries
- «
- ‹
- 1
- ›
- »
